Product image of Cinqaero (Reslizumab) supplied by GNH India

Cinqaero

Active Ingredient:
Reslizumab
Origin:
EU

Cinqaero (Reslizumab)

Cinqaero (Reslizumab) is an intravenous medication used to manage certain inflammatory conditions. This biologic therapy targets specific immune responses, offering a tailored approach to symptom management.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Cinqaero is primarily used for the treatment of eosinophilic asthma, a condition characterized by high levels of eosinophils, a type of white blood cell. It is administered intravenously and is designed to reduce inflammation in the airways. Patients often seek Cinqaero for its potential to improve asthma control and reduce the frequency of asthma attacks. What is Cinqaero used for? It is used to manage symptoms associated with eosinophilic asthma, providing relief for those who do not respond adequately to standard asthma treatments.

Side Effects

  • Common effects of Cinqaero may include reactions at the injection site, such as redness or swelling. Some patients may experience headaches, fatigue, or mild gastrointestinal discomfort. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

  • Cinqaero should be administered under the supervision of a healthcare professional. Patients with a history of severe allergic reactions to biologics should exercise caution. It is important to inform your healthcare provider about any existing medical conditions or medications you are taking before starting Cinqaero.

Avoid Interactions

  • Cinqaero may interact with other medications, particularly those that affect the immune system. It is advisable to avoid alcohol while using Cinqaero, as it may increase the risk of side effects. Always consult your healthcare provider before combining Cinqaero with other treatments.

Frequently Asked Questions

Cinqaero is used to manage symptoms of eosinophilic asthma, a type of asthma characterized by high levels of eosinophils.

Cinqaero is administered intravenously by a healthcare professional.

Common side effects may include injection site reactions, headaches, fatigue, and mild gastrointestinal discomfort.

Cinqaero may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Patients with a history of severe allergic reactions to biologics should exercise caution and consult their healthcare provider before using Cinqaero.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Reslizumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT